Germany
· Delayed Price · Currency is EUR Raffles Medical Group Statistics
Total Valuation
FRA:02M1 has a market cap or net worth of EUR 1.29 billion. The enterprise value is 1.13 billion.
| Market Cap | 1.29B |
| Enterprise Value | 1.13B |
Important Dates
The last earnings date was Friday, April 25, 2025.
| Earnings Date | Apr 25, 2025 |
| Ex-Dividend Date | May 13, 2025 |
Share Statistics
| Current Share Class | 1.85B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.41% |
| Shares Change (QoQ) | -1.59% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 786.25M |
Valuation Ratios
The trailing PE ratio is 29.24 and the forward PE ratio is 27.01.
| PE Ratio | 29.24 |
| Forward PE | 27.01 |
| PS Ratio | 2.42 |
| PB Ratio | 1.71 |
| P/TBV Ratio | 1.76 |
| P/FCF Ratio | 27.17 |
| P/OCF Ratio | 21.10 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.98, with an EV/FCF ratio of 23.74.
| EV / Earnings | 25.55 |
| EV / Sales | 2.17 |
| EV / EBITDA | 12.98 |
| EV / EBIT | 19.20 |
| EV / FCF | 23.74 |
Financial Position
The company has a current ratio of 1.35, with a Debt / Equity ratio of 0.09.
| Current Ratio | 1.35 |
| Quick Ratio | 1.32 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 0.73 |
| Debt / FCF | 1.38 |
| Interest Coverage | 14.72 |
Financial Efficiency
Return on equity (ROE) is 5.91% and return on invested capital (ROIC) is 4.57%.
| Return on Equity (ROE) | 5.91% |
| Return on Assets (ROA) | 3.48% |
| Return on Invested Capital (ROIC) | 4.57% |
| Return on Capital Employed (ROCE) | 7.41% |
| Revenue Per Employee | 178,159 |
| Profits Per Employee | 14,738 |
| Employee Count | 2,989 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 35.60 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -0.74% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -0.74% |
| 50-Day Moving Average | 0.64 |
| 200-Day Moving Average | 0.60 |
| Relative Strength Index (RSI) | 54.54 |
| Average Volume (20 Days) | 1,046 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:02M1 had revenue of EUR 532.52 million and earned 44.05 million in profits. Earnings per share was 0.02.
| Revenue | 532.52M |
| Gross Profit | 239.94M |
| Operating Income | 60.22M |
| Pretax Income | 61.55M |
| Net Income | 44.05M |
| EBITDA | 81.45M |
| EBIT | 60.22M |
| Earnings Per Share (EPS) | 0.02 |
Balance Sheet
The company has 243.23 million in cash and 65.38 million in debt, giving a net cash position of 177.86 million.
| Cash & Cash Equivalents | 243.23M |
| Total Debt | 65.38M |
| Net Cash | 177.86M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 753.74M |
| Book Value Per Share | 0.40 |
| Working Capital | 95.11M |
Cash Flow
In the last 12 months, operating cash flow was 61.05 million and capital expenditures -13.64 million, giving a free cash flow of 47.41 million.
| Operating Cash Flow | 61.05M |
| Capital Expenditures | -13.64M |
| Free Cash Flow | 47.41M |
| FCF Per Share | n/a |
Margins
Gross margin is 45.06%, with operating and profit margins of 11.31% and 8.27%.
| Gross Margin | 45.06% |
| Operating Margin | 11.31% |
| Pretax Margin | 11.56% |
| Profit Margin | 8.27% |
| EBITDA Margin | 15.30% |
| EBIT Margin | 11.31% |
| FCF Margin | 8.90% |
Dividends & Yields
This stock pays an annual dividend of 0.02, which amounts to a dividend yield of 2.53%.
| Dividend Per Share | 0.02 |
| Dividend Yield | 2.53% |
| Dividend Growth (YoY) | 4.74% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 71.62% |
| Buyback Yield | 0.41% |
| Shareholder Yield | 2.95% |
| Earnings Yield | 3.42% |
| FCF Yield | 3.68% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FRA:02M1 has an Altman Z-Score of 3.65.
| Altman Z-Score | 3.65 |
| Piotroski F-Score | n/a |